David W. Dawson2 articles listing David W. Dawson in Nature Communications, PNAS, indexed by Paperzzz from Crossref and OSF.Neoadjuvant modified FOLFIRINOX plus nivolumab in borderline-resectable pancreatic ductal adenocarcinoma: a pilot phase 1 trial Nature CommunicationsSelective targeting of NRF2-high pancreatic ductal adenocarcinoma with an NQO1-activatable prodrug PNAS